During the past decade, Georgia Arrhythmia Consultants conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 9 clinical trials were completed, i.e. on average, 112.5% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Georgia Arrhythmia Consultants" #1 sponsor was "Biotronik, Inc." with 2 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored, "Milestone Pharmaceuticals Inc." with 2 trials sponsored and "American Regent, Inc." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Georgia Arrhythmia Consultants" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Medpace, Inc." with 2 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "IQVIA Biotech" with 1 trials as a collaborator and "Patient-Centered Outcomes Research Institute" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Georgia Arrhythmia Consultants" are "Heart Failure" (7 trials), "Congestive Heart Failure" (2 trials), "Paroxysmal Supraventricular Tachycardia" (2 trials), "Arrhythmia" (1 trials) and "Cardiac Resynchronization Therapy" (1 trials). Many other conditions were trialed in "Georgia Arrhythmia Consultants" in a lesser frequency.

Most popular intervention types in "Georgia Arrhythmia Consultants" are "Drug" (6 trials), "Device" (5 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Empagliflozin" (2 trials), "ACUITY Spiral Left Ventricular Lead" (1 trials), "Aptar Pharma Nasal Spray Bidose System" (1 trials) and "CardioFit® System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Georgia Arrhythmia Consultants" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Georgia Arrhythmia Consultants". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Georgia Arrhythmia Consultants, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Georgia Arrhythmia Consultants, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".